Stroke
📧 Sign up to get email alerts when something new happens for Stroke.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2023-12-19EMA Authorised: Clopidogrel Taw Pharma (previously Clopidogrel Mylan) (clopidogrel hydrochloride) — Taw Pharma (Ireland) Limited
EMA authorised a clopidogrel product (clopidogrel hydrochloride) by Taw Pharma (Ireland) Limited for peripheral vascular diseases, stroke, m…
-
FDA approval · 2023-09-07FDA Approved: CLOPIDOGREL — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) by Apotex Corp., under the ANDA, authorizing a modif…
-
FDA approval · 2023-06-08FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for a generic clopidogrel product from Aurobindo Pharma Limited.
-
FDA approval · 2023-04-21FDA Approved: TICAGRELOR — Original Application (Ascend Laboratories, LLC)
FDA approved Ticagrelor under an Original Application by Ascend Laboratories, LLC. The approval supports its use as an antiplatelet therapy …
-
FDA approval · 2022-09-16FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
FDA approves a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, pertaining to the approved generic prod…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-09-12FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries’ supplemental application for clopidogrel bisulfate, indicating regulatory approval of change…
-
FDA approval · 2022-03-31FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (Radha Pharmaceuticals, Inc.) under an ANDA, confirming its status as a ge…
-
FDA approval · 2021-12-21FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited. The action confirms approva…
-
FDA approval · 2021-10-06FDA Approved: ASPIRIN AND DIPYRIDAMOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for aspirin and dipyridamole from Dr. Reddy's Laboratories Inc, confirming regulatory clearance …
-
FDA approval · 2021-08-11FDA Approved: ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Micro Labs Limited)
FDA approved the original application for a generic aspirin and extended-release dipyridamole combination from Micro Labs Limited.
-
FDA approval · 2021-04-14FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE from Glenmark Pharmaceuticals Inc., USA, authorizing th…
-
FDA approval · 2021-01-15FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic atorvastatin) manufactured by Mylan Pharmaceuticals Inc.
-
FDA approval · 2020-07-24FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application for ramipril (generic ramipril) filed by Chartwell RX, LLC., under ANDA 078745.
-
FDA approval · 2020-07-17FDA Approved: CLOPIDOGREL — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approves Polygen Pharmaceuticals' original ANDA for a generic clopidogrel product.
-
EMA approval · 2020-03-11EMA Authorised: Clopidogrel BGR (previously Zylagren) (clopidogrel (as hydrogen sulfate)) — Biogaran
European Medicines Agency authorised Clopidogrel BGR (clopidogrel as hydrogen sulfate) by Biogaran for peripheral vascular diseases, stroke,…
-
FDA approval · 2019-12-13FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for Clopidogrel Bisulfate from Radha Pharmaceuticals, Inc., confirming approval of their generic pro…
-
FDA approval · 2019-11-06FDA Approved: CLOPIDOGREL — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for clopidogrel under ANDA090844, finalizing an approval for its gen…
-
FDA approval · 2019-11-04FDA Approved: TELMISARTAN — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
The FDA approved a supplemental application for Telmisartan submitted by Jubilant Cadista Pharmaceuticals Inc., under the ANDA pathway. The …
-
FDA approval · 2019-09-20FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for clopidogrel bisulfate manufactured by Aurobindo Pharma Limited, enabling continued marketing…
-
FDA approval · 2019-09-12FDA Approved: CLOPIDOGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for clopidogrel from Amneal Pharmaceuticals LLC under ANDA 203751, confirming changes to the approve…
-
FDA approval · 2019-08-07FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Inc, indicating a supplemental approval …
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for clopidogrel bisulfate by Sun Pharmaceutical Industries, Inc. The approval covers the generic…
-
FDA approval · 2019-05-28FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals Inc.'s Heparin Sodium as an Original Application (ANDA 211007), making a generic injectable anticoagul…
-
FDA approval · 2019-05-24FDA Approved: ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for a generic aspirin and extended-release dipyridamole product.